We use this approach with the aim of blocking the granulocyte-colony stimulating factor receptor (G-CSFR) signaling, a crucial driver of granulopoiesis, that when dysregulated can promote tumor progression and inflammatory diseases [12]. The gene discussed is CSF3R; the disease is neoplasm.